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1. Introduction 
Chlamydia an insidious intracellular pathogen implicated in various diseases by increasing 
inflammation and microbial byproducts. Chronic infection may be observed with major 
types of causative organism initiated disease on ocular, sinopulmonary and reproductive 
tract.  
Chlamydia trachomatis is one of the infectious cause of ocular disease that is endemic in the 
regions with limited sanitary resources. The infection may start on eye lids and progress to 
trichiasis, keratoconjunctivitis and corneal opacity, that eventually lead to vision loss. The 
chronic infection of the same microorganism in female reproductive system may be 
associated with pelvic inflammatory disease, infertility, ectopic pregnancy and is proposed 
to induce ovarian cancer by chronic tubal inflammation. The causative microorganism is 
also demonstrated to be one of the infectious sources of male infertility. Chlamydia 
pneumonia, the other serotype of the microorganism, which is capable of pulmonary 
infection, has been demonstrated to induce nasal polyps, asthma in pediatric and adult 
population.  
Increasing body of evidence indicates that there is an association between chlamydial 
infection with atherosclerosis and serious related outcomes. Inflammation induced by 
peroxy-lipid molecules, heat shock protein 60 (HSP 60) and facilitation of the endothelial 
foam cell formations are the proposed mechanisms.  
Interesting findings in several investigations indicate possible association between 
rheumatoid disease, systemic vasculitis, and certain neurobehavioral diseases such as 
Alzheimer’s disease, multipl sclerosis, seronegative spondylarthritis and Behçet disease and 
Chlamydia.  
Chlamydia is an obligatory intra-cytoplasmal gram negative pathogen that requires 
invading moist epithelial barriers of conjunctiva, sino-bronchial three, and reproductive 
tract for infection. The organism is capable of chronic infection by modulating host 
defense, dormancy or by microbial products. Disease could be occur through direct 
contamination from infected host with touch or dropouts of cough, infected materials or 
with fly vectors.  
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1.1 Ocular complications 
Trachoma is a keratoconjunctivitis caused by ocular infection of C. trachomatis. Serotypes A, 
B, Ba and C are considered to be responsible for disease in corneal epithelium to initiate the 
disease. The latent phase of the disease takes about 4-7 days. Reinfection after initial 
clearance of the organism may occur to clinical signs of the disease. The neonatal form of 
disease also could occur during labor with vaginal serotypes (D and K). Disease is more 
common in lower socioeconomic status, and close living with family members and limited 
access to the clear water resources are indicated as other predisposing factors. Trachoma 
starts on tarsal conjonctiva of the eyelids, progresses to cause trichitis and entropion. 
Disease may cause blindness, advancing to the cornea to cause opacity. Trachoma is 
considered as the primary infectious cause of blindness (Wright, 2007). The global burden of 
the disease has been calculated to reach about 8 billion US dollars including disability 
induced loss of work years, payment for caregivers. Active or early disease which is 
common in the childhood that observed as chronic follicular conjunctivitis, and late 
cicatricial form results of the recurrent inflammation of the infection which leads to corneal 
opacity are the clinical features of trachoma. World Health Organization in collaboration 
with other organizations was initiated to decrease the severe outcomes and disease activity. 
The program which includes surgery for trichiasis, antibiotic therapy for active disease, face 
cleaning or personal hygiene and environmental improvements (SAFE) was constituted in 
1998 that planned to eliminate these complications at 2020 (Burton, 2007). Convincingly, in a 
study conducted in the endemic region for trachoma after mass treatment with 
azithromycin or doxicyclin for C. trachomatis, there was no resistance to the antimicrobial 
treatment (Hong, et al. 2009). Surgical treatment for trichiasis, a late complication of 
trachoma shows promising results, but requires to be continued with scheduled programs 
(Burton et al., 2005a). The severity of the ocular pathology in general, influences the 
duration of the disease that remedy for early intervention in the rural areas such as observed 
in Ethiopia (Melese et al, 2005). On the other hand, azithromycin treatment after surgery for 
controlling the relapses has not been changed the outcome (Burton et al, 2005b).  
Holland et al. demonstrated that the presence of major outer membrane protein to cytotoxic 
T lymphocytes that specific to the C. trachomatis is associated with the current ocular disease 
with longer duration, but neither indicates estimated load of infection nor leads to presume 
the course of the disease (Holland et al., 2006). Repeated infections of Chlamydia may lead to 
expression of heat shock proteins (HSP), which closely react with human HSP 60 and are 
suggested to trigger autoimmune-directed inflammation, which is thought to play role in 
the pathogenesis of trachoma (Morrison et al., 1989).  
In a study based on repeated examination of eyes performed in Australia indicates that C. 
pneumoniae infection was considered as an independent or additional risk factor for age-
related macular degeneration possibly by inducing chronic inflammatory reaction (Robman 
et al., 2005). C. pneumoniae has also been demonstrated to induce chorioidal 
neovascularization by inducing Toll-like receptor 2 in an experimental model indicates a 
risk factor for age related macular degeneration (Fujimoto et al., 2010).  
Ocular adnexial lymhomas constitutes the subgroup of non-hodgkin lymphomas 
originating from lymphoid tissue of mucosal layer. The association between C. psittaci with 
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ocular lymphoma was first determined in a study subjecting Italian patients (Ferreri et al., 
2004). C. psittaci was also indicated as a possible cause with a varying rate of geographical 
distribution (Chanudet et al., 2006). However, several studies failed to demonstrate an 
association between ocular malignancy with Chlamydiae (Yakushijin et al., 2007).  
1.2 Chlamydia and genitourinary tract 
Chlamydia trachomatis is able to infect urogenital tract and is one of the most common 
sexually transmitted diseases in the Western world (Ward, 1995). Other serotypes including 
L1, L2, L2a and L3 are also capable of infecting monocytes to cause systemic disease called 
lympogranulomavenereum (Mabey & Peeling, 2002). The genital serovars of Chlamydiae are 
able to migrate to the upper genital tract to induce quiescent infection, which is one of the 
infectious causes of fallopian tube occlusion, infertility, ectopic pregnancy and salpingitis. 
The microorganism is deficient in producing energy during life cycle and is required to 
attach to the host cell through elementary body (EB) to reach to the Golgi apparatus. The EB 
could be differentiated to the metabolically active non infectious replicative form, namely 
reticulate body (RB), which is able to inhibit cell apoptosis for long term survival. 
Mammalian heat shock proteins are evolutionary highly conserved molecular chaperones, 
which appear to have derived from procaryotic ancestors. Although HSP 60 is primarily 
considered a mitochondrial protein in mammals, 20 to 40% of cellular HSP 60 occurs in 
extra-mitochondrial sites. Amino acid sequences of human HSP 60 and C. trachomatis HSP 
60 (serovar D) are 100% similar. They are identified in four epitopes and 13 other peptides of 
various lengths with identity between 33% and 75%, and these epitopes were present in all 
three domain of the molecule (Capello et al., 2009). Chlamydia trachomatis also secretes HSP 
60 kDalton possibly due to decreasing the external stress to the infection (Morrison, 1991). 
This molecule itself is capable of inducing strong inflammation in  the fallopian tubes and 
antibody responses and similarly cell mediated immunity to HSP 60 is  associated with tubal 
infertility and ectopic pregnancy. The interaction with human HSP 60, which has 48% 
homology with C. trachomatis HSP 60, may induce loss of pregnancy. Women with 
asymptomatic tubal infertility have an increased prevalence of antibodies against C. 
trachomatis and anti-HSP 60 (Sziller et al., 2008). Variety types of chlamydial HSP were 
identified with different properties to induce immunological response (Gérard et al., 2004). 
The implementation of public health measures to diagnose the recent developed infection in 
women at reproductive age and treatment is mandatory especially in the case of genital tract 
infection with the other microorganisms, which may induce the secretion of RB (Caldwell et 
al., 2003). The relevant data do  not support the effectiveness of Chlamydial screening in 
general population younger than 25 years, however, high quality randomized trials  are 
required to determine cost effectiveness or benefits (Low et al., 2009).  
It has been suggested by some that exposure to C. trachomatis HSP 60 may be a risk factor for 
development of cancer (Di Felice et al., 2005), while the development of HSP 60 is also   
proposed to protect against malignancy (Capello et al., 2009). Chronic persistent infection 
with C. trachomatis to the upper genital tract is able to incur significant damage to the 
reproductive tract and proposed to induce ovarian cancer (Quirk & Kupinski, 2001).  
Various mechanisms are suggested for the effect of C. trachomatis inducing male infertility. 
Male reproductive system is separated from innate immunity, which may prevent 
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immunization against one’s own sperm. Infections are proposed to disrupt membranes and 
vascular barriers in testes, epididymis and prostate to initiate autoimmunization through 
introducing sperm with leucocytes or other inflammatory cells. C. trachomatis and N. 
gonorrheae are the most common pathogens for epididymitis and orchitis, which are 
common in the outpatient setting in men between 14 to 35 years of ages (Trojian et al., 2009). 
Although many cases of urethritis are idiopathic, C. trachomatis has been considered the 
most common infectious cause with many of these patients being symptomatic during the 
interview (Wetmore et al., 2009). On the other hand, though there are various studies 
investigating the relationship, influence of prostatitis induced by C. trachomatis on male 
infertility is uncertain (Cunningham & Beagley, 2008). The surface membrane of sperm has 
various types of protein including HSP 65 and 70, which react with anti-sperm human IgG 
antibodies. Three of these proteins were also immunoprecipitated against C. trachomatis 
epitope of HSP 70, suggesting an association between genital tract infection, immunity to 
HSP 70 and reproductive failure (Naaby-Hansen & Herr, 2010). The influence of 
leucocytospermia and DNA particles of sexually transmitted diseases (STD) on 
asymptomatic male infertility was investigated in a study conducted by Bezold et al. (Bezold 
et al., 2007). The incidence of STD was similar between patients with or without 
leucocytospermia. DNA particles from STD decreased sperm and motile sperm 
concentration, total sperm count, and neutral ǂ-glucosidase concentration, whereas 
leucocytospermia was associated with a decrease in total sperm count, % of normal forms, 
and fructose concentration. In addition to the decrease of spermatogenesis due to the 
destruction of reproductive system, male infertility seems to be influenced by both the 
infection itself and increased inflammation. In an in-vitro study, the persistence of C. 
trachomatis was demonstrated in the presence of ciprofloxacin and to a lesser extent of 
ofloxacin. These results reflect the clinical data that antibacterial susceptibility does not 
always guarantee the in-vivo success of the therapy (Dreses-Werringloer et al., 2000).  
The association between prostate cancer and C. trachomatis infection was not determined, 
however increased seropositivity was found in men with benign prostate hyperplasia, 
suggesting inflammation-induced or facilitated enlargement (Hracek et al., 2011). 
1.3 Chlamydia and respiratory system 
Respiratory system is an important route of infection for Chlamydia pneumoniae. The 
microorganism is determined to be one of the infectious causes of sinusitis, otitis media, 
tonsillitis, laryngitis and chronic pharyngitis (Hsahiguchi et al., 1992, Hammaerschlag, 
2000). Chronic infection in the upper respiratory tract was demonstrated to cause nasal 
polyps from the biopsy materials, possibly with increasing inflammation and epithelial cell 
destruction (Apan et al., 2007).  
C. pneumonia is responsible for about 10-15% of community acquired pneumonias. C. 
trachomatis is also able to cause nasopharyngitis and pulmonary infection especially in the 
newborns. Infection may occur by direct transmission during the vaginal delivery and may 
be serologically positive in the earlier years of life. However, vertical transmission from the 
mother may result in the development of the neonatal conjunctivitis and pneumonia (Wu et 
al., 1999, Darville, 2005). Seropositivity to the C. pneumonia  was found to be as high as 50% 
in young adults and 75% for the elderly (Oba & Salzman, 2007).  
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A substantial body of evidence indicates the role of chronic infections in chronic 
pulmonary disease. The mechanism of chronic infection in disease process is not clear, but 
may involve a modification of the airway inflammatory response. Asthma is characterized 
by T-helper lymphocyte induced eosinophilic response that proceed to airway mucosal 
damage and increased responsiveness. There was no difference between the subjects who 
had atypical C. pneumonia and those who had nonatypical pneumonia in terms of asthma 
incidence, indicence being very high in both groups (Sutherland et al., 2004). Both of two 
serotypes of Chlamydiacea family were considered as infectious etiology for asthmatic 
patients in pediatric populations. Increased prevalence of viable C. pneumoniae was 
detected in samples from bronchoalveolar fluid in pediatric asthmatic patients, which   
constitutes about the half of the polymerase chain reaction (PCR) positive subjects with 
the microorganism (Webley et al., 2005). Chlamydia specific DNA strand was detected 
from bronchoalveolar fluid in about 67 % of pediatric asthmatic patients. On the other 
hand, this observation is not able to explain 71% positive results obtained from PCR in 
non-asthmatic patients and increased incidence of asthma that was observed in certain 
subgroups (Webley et al., 2009).      
C. pneumoniae is a causative organism in chronic severe form of asthma (Cook et al., 1998). 
Raised antibody titer to C. pneumoniae IgA was associated with increased neutrophil, 
monocyte count, and eosinophilic cationic protein in acute exacerbation of asthma (Wark et 
al., 2002). Elevated IgA antibody levels to C. pneumoniae were more commonly encountered 
in severe and moderate forms of asthma, suggesting chronic infection. However, antibody 
to C. pneumoniae HSP 60 was not considered as a useful marker of such an infection among 
the asthmatics (Hertzen et al., 2002).  
Chronic obstructive pulmonary disease (COPD) is another chronic pulmonary pathology, 
which is leading cause of morbidity and mortality. There is a strong correlation between 
disease and smoking habit and about 10-20% of smokers developing COPD. Chronic C. 
pneumoniae infection as determined by persistent elevated IgA levels to the microorganism 
was associated with COPD and considered as an independent risk factor (Brandén et al., 
2005). The relationship between severities of the disease and C. pneumoniae IgA antibody 
was demonstrated in another study, in which peak expiratory flow percentage of the 
predictive value was inversely correlated with the IgA antibody titers (Falck et al., 2002). On 
the other hand, the prevalence of IgG and IgM antibodies indicating acute infection was 
significantly increased in COPD patients when compared to the smoker control subjects, but 
no significant relation was found with IgA antibodies. Smoking was associated with 
increased level of C. pneumoniae serum antibody levels. It is presumed that smoking may 
facilitate C. pneumoniae infection in lung with chronic epithelial damage or promote deeper 
penetration into lung tissue to produce a greater antibody response (Karnak et al., 2001). 
High IgG and IgA antibody titers against C. pneumonia are linked with the severity of 
emphysema high resolution CT and increased IgA titers is also associated with decreased 
diffusion capacity to carbon monoxide (Kurashima et al., 2005).  
Evidence indicates that there is a relation between chronic pulmonary infection with C. 
pneumonia and lung cancers. Antibody titer against to this organism is increased in cancer 
patients (Littman et al., 2004). The risk of cancer may increase about twofold in patients with 
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elevated Ig A titers, specifically in squamous cell carcinomas and to a lesser extent in small 
cell and adenomatous cancers (Laurila et al., 1997). Increased seropositivity was found 
among smoker patients diagnosed with small cell cancer. This point rise concern about 
infection, which may be facilitated with chronic airway irritation with cigarette or chronic 
infection combined with increase in epithelial cell turnover that eventually leads to cancer 
(Samaras et al., 2010).  
1.4 Chlamydia and atherosclerosis 
Atherosclerosis is the main cause of death in the developed countries, inducing coronary 
heart disease, stroke or advancing organ failure. There are many contributing factor such as 
cigarette smoking, sedentary life style, increased weight due to hyper caloric, hyper 
cholesterolemic dietary habit, and low exercise. An association between atherosclerosis and 
infections has been suggested many times during the past century.  
C. pneumonia, one of the infectious etiologies of atherosclerosis, was first demonstrated in 
the study conducted by Saikku et al. (Saikku et al, 1988). The microorganism first appears in 
the lower respiratory tract infected alveolar macrophages that transmigrate from the 
epithelium gain access to the circulation and reach atherosclerotic plaque. C. pneumonia may 
be capable of infecting a variety of cells including macrophages, vascular endothelial and 
smooth muscles. The lypopolisaccaride (LPS) component of the gram negative bacterial 
capsule is a potent inflammatory molecule, which changes the biology of the alveolar 
macrophages to attract low density lipoproteins and change their morphology (Mackman, 
2000). The presence of organism on atherosclerotic plaque has been shown by various 
techniques, including PCR, immunohistochemistry, and electron microscopy (Leinonen & 
Saikku, 2002, Campbell & Kuo, 2004). The fact that organism is present in the atherosclerotic 
plaque but is rarely found in the healthy vasculature indicates that microorganism might 
spread through dissemination from primary infectious site with immune cells, namely T 
lymphocytes or monocytes (Liu et al., 2005). Also, it possibly requires weak regions between 
cell connections in endothelial layers for diapedes. Therefore, randomized antimicrobial 
programs were implemented to eradicate the infectious agent and failed success of long 
term therapies increased suspicion of atherogenesis theory. However, C. pneumonia is one of 
the possible causative organisms and all microorganisms can not be eradicated with a single 
antimicrobial agent. Recent cohort studies also indicated that antichlamydial therapy in 
Chlamydia positive patients led to no symptomatic improvement in peripheral vascular 
disease (Jaff et al., 2009). There is also no association between C. pneumonia bacteriophage or 
its antibody titers and acute coronary events (Patrick et al., 2005).  
Beside the contributing factors, atherosclerosis may be initiated not only by direct invasion 
of microorganism itself but also by increasing and ongoing inflammation with such 
organisms. Inflammatory stimuli such as lipopolysaccarides of microorganisms may 
activate toll-like receptors (TLR) from immune response from macrophages and endothelial 
or smooth muscle cells. Once initiated, TLR are able to initiate inflammatory storm. Inborn 
deficiency including weaker response to the inflammatory stimuli may protect against 
cardiovascular diseases (Kiechl et al., 2002). Transient stimuli from certain microorganism 
had been found to be capable of inducing stimuli to TLR even when causative agent was 
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undetected (Stassen et al., 2008). Leucocyte recruitment and accumulation to the atheroma 
initiates the second morphological event that accumulates lipid and changes to the foam 
cells. Smooth muscle cell migration and replication from underlying media to intima and 
cell death might complicate the atheroma. Volume increase under intima may lead to the 
rupture of underlying arterial vasa vasorum by restricting adequate oxygen or nutrient 
intake and hemorrhage may lead to further smooth muscle cell accumulation. The 
presence of C. pneumonia in the plaque may further augment the local inflammatory 
process. The other possible molecular mechanism induced by C. pneumonia is up-
regulation and expression of HSP 60, which induces cytokines including tumor necrosis 
factor-ǂ, interleukine-1ǃ (IL1 ǃ), IL 6, matrix metalloproteinases (MMP) from 
macrophages. In addition, C. pneumonia might increase C reactive protein and contribute 
to instability or progression of the plaque (Miya et al., 2004). Specific microbial products 
such as LPS, HSP 60 or other virulence factors may provoke endothelial cell, producing 
remote infections. Also, the acute inflammation activates coagulation and fibrinolytic 
system, which changes balance in pro-coagulation site. Rupture of the plaque from its 
thinned fibrous cap and release of non-occlusive thrombi might produce clinically 
apparent occlusion in this activated coagulation state (Fazio et al., 2009). Infection with C. 
pneumonia is possibly involved with the pathogenesis of atherosclerosis early in life, such 
that antichlamydial antibiotic has no influence once inflammation and plaque has been 
established (Gattone et al., 2001). The organism may accelerate the progression of 
atherosclerosis by increasing and maintaining inflammation. It has been postulated in 
mice model that acceleration of atherosclerosis may be mediated through TLR and 
myeloid differentiation factor with liver X receptor, which is important for cholesterol 
transportation (Naiki et al., 2008). In another animal model, an anti-oxidant, retinoic acid 
has been found to be effective against C. pneumonia-induced atherosclerosis by reducing 
foam cell formation in atherosclerotic lesions (Jiang et al., 2008). Recent evidence indicates 
that C. pneumonia may induce apoptosis and endothelial cell necrosis in the latter course 
of the infection, which is shown by the presence of chlamydial HSP 60 and with high 
mobility box protein 1, a strong pro-inflammatory molecule (Marino et al., 2008). 
However, inflammatory reaction seems to be host dependent and polyvalent in etiology. 
High antibody response is considered to be a more consistent marker for inflammation 
than seropositivity alone and high antibody response to multiple pathogens is a stronger 
marker of any single pathogen. Strong association was found between IL-6, CRP and 
fibrinogen levels with antibody levels (Nazmi et al., 2010). These findings may be partially 
explained the discrepancy between conflicting results arising on atherosclerosis, in studies 
which have methodological diversities. 
1.5 Chlamydia and neurologic disorders 
C. pneumonia may contribute to advancing atherosclerotic disease, which eventually leads to 
ischemic stroke. The presence of C. pneumonia was demonstrated in more than 70% of the 
severely stenotic specimens of carotic artery with immunohistochemical studies (Vink et al., 
2001). The antibody titers including IgG and IgA against the organism were found to be 
higher especially in young stroke patients. Authors indicated that IgA class antibody titers 
were more important due to the limited half life and determined the persistence of chronic 
infection (Piechowski-Jóźwiak et al., 2007). There was an association between the risk of 
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ischemic stroke and serum IgA titers, especially in large vessel atherosclerotic and lacunar 
stroke (Elkind et al., 2006). On the other hand, strong evidence on the relation between IgA 
titers and chronic infection is lacking because of inter-laboratory differences, limited half life 
and possible cross reactions with other types or microorganisms. Anti-C. pneumoniae 
antibodies were evaluated in HIV infected patients with coronary atherosclerosis. When 
atherosclerotic plaques from autopsy specimens were evaluated, there was limited data 
indicating the presence of C. pneumoniae in small cerebral vessels (Voorend et al., 2008). In a 
study conducted by Maggi et al, (Maggi et al, 2006) no significant difference was found 
between individuals in terms of IgA and IgG titers and no subject was positive for IgM, 
which led them to conclude that the damage of the carotid wall in patients infected with 
HIV-1 was not due to C. pneumonia. In contrast, C. pneumonia was found to be a risk factor 
for cardiovascular disease in HIV infected patients with low CD4 level and high HIV load 
(Tositti et al, 2005). The concurrence of hypercholesterolemia with C. pneumonia infection 
increased the risk of atherosclerosis by about three fold (Gaona-Flores et al, 2008). It has 
been also suggested that infected carotid plaques contribute to the systemic inflammatory 
markers in patients with stroke risk. The significant association of lipoprotein and 
phospholipase-A2 with of C. pneumoniae suggests an interaction between them in 
accelerating inflammation in atherosclerosis (Atik et al, 2010). There is limited data 
concerning genetic predisposition to the C. pneumoniae infection. Strong association was 
found between HLA B35 allele and serologic markers. Male sex and chronic smoking further 
increased the possibility of infection (Palikhe et al, 2008).  
As an obligatory intracellular pathogen, C. pneumonia is able to reside in monocytes and 
macrophages of tissues and able to be reactivate according to the life cycle and host defense. 
It was proposed that, long term exposure to inflammatory cytokines and endothelial 
response may induce certain neurodegenerative disease including Alzheimer’s disease, 
multiple sclerosis (MS), meningoencephalitis and neurobehavioral disorders (Yucesan & 
Sriram, 2001, Stratton & Sriram, 2003). 
Alzheimer’s disease (AD) causes dementia with advancing age with the atrophy or death of 
the certain regions of brain. Two clinical form of disease has been classified as genetically 
determined: namely, early onset and late onset non-familial and progressive 
neurodegenerative form, which is the most common and severe form of dementia. The 
association between AD with C. pneumoniae infection was first demonstrated by Balin et al, 
and 90% positivity was shown in brain specimens using PCR technique. Electron 
microscopic and immunohisto-chemistry studies also indicated that EB and RB like particles 
were found in the brains of affected individuals, while no labeling was detected in controls 
(Balin et al.,1998). These results were further confirmed in a study subjecting brain 
specimens of AD and controls during autopsy in which increased prevalence of C. 
pneumonia RNA was observed with AD (Gérard HC et al, 2006). Furthermore, strong 
association was determined between apolipoprotein E ε4 genotype and C. pneumoniae 
(Gérard HC et al., 1999). The olfactory epithelium has been proposed as the primary 
infectious site and the pathogen seems to reach to the olfactory bulb and olfactory cortex 
and then neuronal damage may progress (Balin & Appelt, 2001). Long term antibiotic 
therapy, including doxycycline and rifampin, slowed the course of cognitive impairment 
(Loeb et al., 2004). Metal protein attenuating compounds have been shown to decrease 
beta amyloid plaques in animal models and antiprotozoal metal chelator clioquinol was 
used for treatment (Finefrock et al., 2003, Cahoon, 2009). C. pneumoniae is also associated 
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with AIDS-demantia complex, a HIV-induced inflammatory parenchymal disorder of the 
brain. The presence of microorganism was confirmed at a high rate in using PCR. These 
findings should be cautiously interpreted as whether the source of infection is reactivation 
due to immune suppression or superimposed recent infection remains to be clarified 
(Contini et al., 2003).  
Multiple sclerosis (MS), an autoimmune chronic demyelinating disorder of the CNS with 
unknown etiology appears with episodes of remission and relapse, or is present in   
progressive forms. Disease has high economic burden and disability potential and affects 
about 1-2 person in 1000. Perivascular inflammation, gliosis and demyelinating plaque 
formations are considered as classical the pathologic features (Barnett & Sutton, 2006). 
Perivascular cell infiltration was presumed to initiate the involvement of glial cells in the 
earlier and astrocytes in the later phase of the disease. Various types of microorganisms 
including Chlamydia are assumed to induce inflammation through TLR 3 and 4 dependent 
mechanisms (Joyee & Yang, 2008). Genetic predisposition with a combination of infectious 
agents has been implicated in MS pathogenesis. The presence of C. pneumoniae is still under 
debate and shows a great variability from 0 to 43% in different studies using PCR 
techniques (Contini et al., 2010). Several authors indicate that the presence of microorganism 
may partially influence the occurrence of MS, being linked to the progressive form of the 
disease (Munger et al, 2003). When compared to the controls, the increased frequency of 
detection of HSP 60 and 16S rRNA in the CSF samples from MS patients indicates the 
metabolic activity of the microorganism (Dong-Si et al., 2004). Intrathecal synthesis of anti-
chlamydial IgG, indicating the infectious cause, was more frequent in MS patients than in 
non-infectious neural diseases (Fainardi et al., 2004). The increased presence of C. pneumonia 
was demonstrated in a study investigating autopsy samples of MS patients, which looked 
for anti-chlamydial monoclonal antibodies using immunohistochemical staining in brain 
slices. The electron microscopy also detected chlamydial EB in four of ten MS patients but 
none in the controls (Sriram et al., 2005). A large meta-analysis including 26 studies was not 
able to conclude that C. pneumoniae as a causal relationship with MS (Bagos et al., 2006). Anti 
microbial therapy in patients with MS requires validated multi-central studies, involving all 
infectious cycles of the microorganism (Stratton & Wheldon, 2007). The current information 
indicates that, the causal relationship between C. pneumoniae with MS is still controversial. 
Infection may be activated or supervene in the course of the disease.  
There is a paucity of reports regarding the relation of C. pneumoniae with 
meningoencephalitis. These patients are young, have neurological symptoms or 
radiographic evidence and also have acute symptoms of respiratory infection, and 
laboratory evidence indicating C. pneumoniae. Acute demyelinating encephalitis, cerebellar 
axatia and Gullian Barre are some of the clinical forms in which faster recovery after 
antibiotic therapy demonstrates the relation between microorganism and neurological 
presentations (Contini et al., 2010).  
Reports indicating relationship between C. pneumoniae and affective and neurobehavioral 
diseases are also sparse. Autism spectrum disorders (ASD), constitute a group of 
behavioral diseases such as autism, attention deficit disorder, Asperger’s syndrome with 
unknown etiology. Genetic predisposition, environmental factors, educational and 
socioeconomic status of the family was determined as possible reasons (Nicholson & 
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Sztmari, 2003). Infection may be a cofactor in progression of the disease and C. pneumoniae 
is considered as a causative organism along with Mycoplasma species or infections from 
herpes virus (Chia & L.Y. Chia, 1999). Chlamydiacea family has been postulated to cause of 
schizophrenia owing to persistence of high IgA levels in subjects. Fellerhoff et al. found a 
significant prevalence of C. psittaci, C. pneumoniae, and C. trachomatis (50%) compared to 
the controls (~7%). While antipsycotic drugs were inefficient, treatment including in-vitro 
activated immune cells and antibiotics showed improvement of the mental illness 
(Fellerhoff et al., 2005).  
1.6 Chlamydiaceae and systemic disorders 
Reactive arthritis is currently accepted to be associated with Chlamydial infections or other 
enteric or sexually acquired infections. 
C. trachomatis and to a lesser extent C. pneumonia is determined to be one of the most 
common infectious etiological agents in reactive arthritis (Carter, 2006, Braun et al, 1994). 
Specifically, Chlamydial source of reactive arthritis was estimated about to be ~5% and 78% 
of these infections were dormant and asymptomatic during initial infection (Rich et al., 
1996). In comparison with osteoarthritis, Chlamydia species have been demonstrated to be 
associated with undifferentiated spondylarthritis (a subgroup of reactive arthritis) using 
PCR at a higher rate in synovial tissue, than blood serological values. The genetic 
background influencing predisposition or host defense of Chlamydia-induced arthritis 
remains to be elucidated and HLA-B27 positivity was found to be lower than the other 
source of reactive arthritis and appeared to be less progressive in HLA-B27 negative patients 
(Carter et al., 2009). Increased frequency of C. trachomatis infection was also detected in 
patients with ankylosing spondilitis as determined with serologic analysis including 
immunoblotting (Csango et al., 1987). In addition, psoriatic arthritis (PsA) seems to be a 
candidate for investigations on the etiologic role of chlamydial infections. In their study 
Silveira et al (Silveira et al., 1993) indicated the prevalence of C. trachomatis infection in 
patients with SpA, which demonstrated a significant frequency of positive urogenital C. 
trachomatis culture (22%) as well as elevated levels of IgG antibodies (36%) or IgM antibodies 
(14%) against C. trachomatis in patients with PsA. On the contrary, there was only association 
of rheumatoid arthritis with C. trachomatis in a study investigating the possible infectious 
etiology in patients with different group of seronegative spondyloarthropathies (Lapadula 
et al., 1988).  
The infectious etiology in diabetes has not been confirmed due to its relatively lower 
incidence compared with the seropositivity of the possible community acquired 
microorganisms (Lutsey et al., 2009). Yet, several studies indicate that infection with C. 
pneumoniae might influence the time related outcome of diabetes in a subgroup of patients, 
thought to be a possible genetic predisposition. C. pneumoniae with chronic low grade 
inflammation induces insulin resistance in healthy middle aged man and correlation 
increased with body mass index and seropositivity to the multiple microorganisms 
(Fernández-Real et al., 2006). These results were further confirmed with an animal model 
demonstrating that C. pneumoniae induces long lasting insulin resistance and inflammation 
in obese mice. Anti TNF-ǂ or antibiotic treatment prevents insulin resistance (Wang et al., 
2009). Increased seropositivity to C. pneumoniae IgA and IgG in diabetes was associated with 
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the secondary cardiovascular events including myocardial infarction, stroke, or 
cardiovascular death, having possible relation with chlamydial HSP 60. The relation or role 
of human HSP 60 in disease progress and complications remains to be determined with 
large scale prospective studies (Guech-Ongey et al., 2009).  
Behçet‘s disease (BD) is an inflammatory disorder of unknown etiology characterized by 
recurrent oral aphtous ulcers, genital ulcers, uveitis and skin lesions. Patients with BD 
demonstrated increased IgA and IgG titers to C. pneumoniae when compared with controls 
(Ayaşlıoğlu et al., 2004). Intestinal lesions of BD expressing  interferon-Ǆ, tumor necrosis 
factor-ǂ, interleukin 12 mRNA and HSP 60 indicates possible involvement  of microbial HSP 
60 in the pathogenesis of intestinal BD, but   the relation with Chlamydiae remains to be 
determined (Imamura et al., 2005).  
2. Conclusion 
The serotypes of Chlamydiaceae tend to cause chronic infection and are involved in various 
types of disorders. Lacks of standardized methods for diagnosis or laboratory tests that 
partially reflect the activity of the microorganism is the main problem. Further insight on the 
life cycle of these ubiquitous bacteria’s is mandatory, especially on HSP 60 and interactions 
with host, to elucidate the therapeutic options better. Genetic predisposition is another issue 
that needs to be illuminated to determine the individuals who are prone or resistant to 
disease activity.  
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